Section content
- Portfolio valuation methodology
- New investment analysis
- Portfolio analysis
- Realisations analysis
- Funds under management
- Private equity and venture capital - a lexicon
Portfolio analysis
Portfolio value by business line (£m) |
2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|
Buyouts | 1,570 | 1,480 | 1,197 | 1,152 | 1,183 |
Growth Capital | 1,226 | 1,214 | 2,000 | 2,647 | 2,710 |
Venture Capital | 743 | 672 | 742 | 1,310 | 1,912 |
SMI | 762 | 960 | - | - | - |
Total | 4,301 | 4,326 | 3,939 | 5,109 | 5,805 |
Portfolio value by geography (including co-investment funds) (£m) |
|||||
UK | 2,751 | 3,024 | 3,041 | 4,018 | 4,792 |
Continental Europe | 2,427 | 2,299 | 1,773 | 1,984 | 2,039 |
US | 281 | 241 | 182 | 270 | 246 |
Asia | 102 | 86 | 101 | 101 | 98 |
Total | 5,561 | 5,650 | 5,097 | 6,373 | 7,175 |
Portfolio value by geography (3i only - excluding co-investment funds) (£m) |
|||||
UK | 2,253 | 2,506 | 2,494 | 3,386 | 4,121 |
Continental Europe | 1,688 | 1,511 | 1,175 | 1,373 | 1,363 |
US | 272 | 234 | 180 | 264 | 235 |
Asia | 88 | 75 | 90 | 86 | 86 |
Total | 4,301 | 4,326 | 3,939 | 5,109 | 5,805 |
Continental European portfolio value (£m) |
|||||
Benelux | 180 | 181 | 101 | 78 | 92 |
France | 291 | 234 | 186 | 253 | 254 |
Germany/Austria/Switzerland | 499 | 454 | 319 | 385 | 556 |
Italy | 69 | 53 | 69 | 103 | 142 |
Nordic | 344 | 332 | 273 | 304 | 26 |
Spain | 249 | 224 | 211 | 222 | 234 |
Other European | 56 | 33 | 16 | 28 | 59 |
Total | 1,688 | 1,511 | 1,175 | 1,373 | 1,363 |
Other European includes investments in countries where 3i did not have an office at 31 March 2005. | |||||
Portfolio value by FTSE industrial classification (£m) |
|||||
Resources | 161 | 155 | 186 | 268 | 232 |
Industrials | 1,074 | 1,018 | 944 | 1,117 | 1,081 |
Consumer goods | 964 | 1,026 | 873 | 1,080 | 1,237 |
Services and utilities | 1,212 | 1,275 | 1,018 | 1,318 | 1,538 |
Financials | 331 | 238 | 274 | 273 | 256 |
Information technology | 559 | 614 | 644 | 1,053 | 1,461 |
Total | 4,301 | 4,326 | 3,939 | 5,109 | 5,805 |
Portfolio value by valuation method (£m) |
|||||
Imminent sale or IPO | 373 | 174 | 37 | 51 | 106 |
Listed | 179 | 225 | 187 | 413 | 818 |
Secondary market | 31 | 29 | 30 | 89 | 266 |
Earnings | 1,138 | 1,347 | 938 | 1,210 | 1,033 |
Cost | 468 | 509 | 607 | 1,077 | 1,078 |
Further advance | 203 | 149 | 155 | 186 | 244 |
Net assets | 92 | 103 | 139 | 132 | 147 |
Other (including other Venture Capital assets valued below cost) | 417 | 328 | 282 | 219 | 157 |
Loan investments and fixed income shares | 1,400 | 1,462 | 1,564 | 1,732 | 1,956 |
Total | 4,301 | 4,326 | 3,939 | 5,109 | 5,805 |
Buyout portfolio value by valuation method (£m) |
|||||
Imminent sale or IPO | 134 | 59 | - | - | - |
Listed | 72 | 79 | 46 | 93 | 215 |
Secondary market | 1 | 1 | 6 | 12 | 16 |
Earnings | 372 | 472 | 245 | 204 | 140 |
Cost | 71 | 58 | 93 | 64 | 76 |
Net assets | 4 | 2 | 7 | 9 | 6 |
Other | 47 | 20 | 32 | 14 | 9 |
Loan investments and fixed income shares | 869 | 789 | 768 | 756 | 721 |
Total | 1,570 | 1,480 | 1,197 | 1,152 | 1,183 |
Growth Capital portfolio value by valuation method (£m) |
|||||
Imminent sale or IPO | 120 | 49 | 23 | 42 | 62 |
Listed | 29 | 60 | 102 | 177 | 313 |
Secondary market | 7 | 6 | 6 | 13 | 25 |
Earnings | 360 | 350 | 658 | 967 | 850 |
Cost | 159 | 171 | 230 | 284 | 175 |
Further advance | 14 | 15 | 14 | 24 | 22 |
Net assets | 32 | 39 | 131 | 115 | 140 |
Other | 184 | 145 | 135 | 155 | 67 |
Loan investments and fixed income shares | 321 | 379 | 701 | 870 | 1,056 |
Total | 1,226 | 1,214 | 2,000 | 2,647 | 2,710 |
Venture Capital portfolio value by valuation method (£m) |
|||||
Imminent sale or IPO | 33 | 36 | 14 | 9 | 44 |
Listed | 63 | 62 | 39 | 143 | 290 |
Secondary market | 19 | 19 | 18 | 64 | 225 |
Earnings | 22 | - | 35 | 39 | 43 |
Cost | 221 | 257 | 284 | 729 | 827 |
Further advance | 186 | 119 | 141 | 162 | 222 |
Net assets | 1 | 1 | 1 | 8 | 1 |
Other Venture Capital assets valued below cost | 82 | 51 | 79 | 23 | 15 |
Other | 55 | 66 | 36 | 27 | 66 |
Loan investments and fixed income shares | 61 | 61 | 95 | 106 | 179 |
Total | 743 | 672 | 742 | 1,310 | 1,912 |
- of which early stage Venture Capital | 561 | 456 | 589 | 1,042 | 1,368 |
SMI portfolio value by valuation method (£m) |
|||||
Imminent sale or IPO | 86 | 30 | - | - | - |
Listed | 15 | 24 | - | - | - |
Secondary market | 4 | 3 | - | - | - |
Earnings | 384 | 525 | - | - | - |
Cost | 17 | 23 | - | - | - |
Further advance | 3 | 15 | - | - | - |
Net assets | 55 | 61 | - | - | - |
Other | 49 | 46 | - | - | - |
Loan investment and fixed income shares | 149 | 233 | - | - | - |
Total | 762 | 960 | - | - | - |
Venture Capital portfolio value by sector (£m) |
|||||
Healthcare | 236 | 231 | 253 | 400 | 359 |
Communications | 183 | 168 | 151 | 242 | 493 |
Electronics, semiconductors and advanced technologies | 140 | 101 | 107 | 186 | 192 |
Software | 184 | 172 | 231 | 482 | 868 |
Total | 743 | 672 | 742 | 1,310 | 1,912 |
Back to top